Wasatch Advisors’s BioDelivery Sciences International, Inc. BDSI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-2,254,592
Closed -$6.99M 285
2021
Q4
$6.99M Sell
2,254,592
-3,160,555
-58% -$10.6M 0.03% 218
2021
Q3
$19.5M Sell
5,415,147
-131,340
-2% -$495K 0.08% 174
2021
Q2
$19.9M Sell
5,546,487
-75,662
-1% -$267K 0.08% 181
2021
Q1
$22M Buy
5,622,149
+1,038,060
+23% +$4.29M 0.1% 169
2020
Q4
$19.3M Buy
4,584,089
+2,524,858
+123% +$9.73M 0.09% 149
2020
Q3
$7.68M Buy
2,059,231
+602,574
+41% +$2.56M 0.05% 184
2020
Q2
$6.35M Buy
1,456,657
+221,564
+18% +$996K 0.05% 185
2020
Q1
$4.68M Sell
1,235,093
-96,338
-7% -$473K 0.05% 176
2019
Q4
$8.41M Buy
+1,331,431
New +$7.83M 0.07% 163

Other funds holding BDSI

Wasatch Advisors's BDSI Position: Q1 2022 in Review

Wasatch Advisors sold out of BioDelivery Sciences International, Inc. (BDSI) in Q1 2022, closing a stake of 2,254,592 shares — an estimated $6.99M sold.

Wasatch Advisors first reported a position in BDSI in Q4 2019 and held it in 9 quarters. The position peaked at $22M in Q1 2021. 2 funds tracked by Wall St. Rank hold BDSI as of Q1 2022.

  • Wasatch Advisors reported no remaining BioDelivery Sciences International, Inc. position as of Q1 2022 after selling out during the quarter.
  • Wasatch Advisors sold 2,254,592 BioDelivery Sciences International, Inc. shares in Q1 2022, an estimated $6.99M.
  • Wasatch Advisors first reported a position in BioDelivery Sciences International, Inc. in Q4 2019 and held it in 9 quarters.
  • Wasatch Advisors's BioDelivery Sciences International, Inc. position peaked at $22M in Q1 2021.
  • 2 funds tracked by Wall St. Rank held BioDelivery Sciences International, Inc. as of Q1 2022.

Based on Wasatch Advisors's 13F filing for Q1 2022, filed 13 May 2022.